Olfactory domain family protein 3 promotes the proliferation of MYCN-amplified neuroblastoma cell lines in vitro
Objective To explore the function of olfactomedin domain family protein 3 (OLFM3) in neuroblastoma (NB). Methods The relationship between the expression of OLFM3 mRNA and v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog(MYCN)amplification status and the prognosis of patien...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
2025-02-01
|
| Series: | Jichu yixue yu linchuang |
| Subjects: | |
| Online Access: | https://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2025-45-2-168.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Objective To explore the function of olfactomedin domain family protein 3 (OLFM3) in neuroblastoma (NB). Methods The relationship between the expression of OLFM3 mRNA and v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog(MYCN)amplification status and the prognosis of patients in NB clinical samples were clarified by using R2 Genomics Analysis and Visualization Platform. Depmap database was used to examine the expression level of OLFM3 in different tumors cell lines and to identify the correlation between OLFM3 expression and MYCN amplification status in various NB cell lines. RT-qPCR and Western blot were used to detect the knockdown level of OLFM3. Cell proliferation was monitored using crystal violet staining and real-time cellular analysis. The colony formation ability of NB cells was assessed using colony-forming unit assay. Results Analysis of R2 database revealed higher level of OLFM3 expression in MYCN-amplified NB clinical samples(P＜0.001). Patients with high OLFM3 expression showed a significantly lower overall survival probability compared to those with low OLFM3 expression(P＜0.05). Analysis with Depmap database revealed that the expression level of OLFM3 was higher in NB than that in other kind of tumor. The expression level of OLFM3 was significantly higher in the MYCN-amplified cell lines than in the MYCN-non-amplified cell lines(P＜0.01). In MYCN-amplified NB cells, knockdown of OLFM3 inhibited cells proliferation(P＜0.001) and colony formation(P＜0.001), but there was no noticeable changes observed in MYCN-non-amplified cells. Conclusions OLFM3 specifically promotes the proliferation of MYCN-amplified NB cells, but has a less effect on MYCN-non-amplified cells, indicating it is a potential biomarker for high-risk MYCN-amplified NB. |
|---|---|
| ISSN: | 1001-6325 |